Skip to content
Tenfell
Awarded contract
Published 02 Mar 2021

Contract award – The NHS Commissioning Board (operating under the name of NHS England)

The NHS Commissioning Board (operating under the name of NHS England) · United Kingdom

Key facts

Contract value
€560,084,390
Awarded
10 Feb 2021
Contract starts
01 Mar 2021
Contract ends
28 Feb 2023
Procedure
Open procedure
Buyer type
Health

Awarded to 28 suppliers

SupplierValue
Accord-UK Ltd—
Allergan Limited—
Chugai—
Eli Lilly & Company Ltd—
Ferring Pharmaceuticals Limited—
Ipsen—
Janssen-Cilag Ltd—
Merck Serono Limited—
Merz—
Napp Pharmaceuticals—
Novo Nordisk—
Pharmacosmos UK Ltd—
Pfizer Ltd—
Roche Products Ltd—
Vifor Pharma UK Limited—
Sandoz Ltd—
Teva UK Ltd—
Amgen Ltd—
AstraZeneca—
Organon Pharma (UK) Ltd.—
Gedeon Richter UK Ltd—
Merck Sharpe & Dohme (UK) Limited—
Biogen—
Bristol Myers Squibb—
Celltrion Healthcare United Kingdom Limited—
Novartis Pharmaceuticals UK Ltd—
Thornton & Ross Ltd—
UCB Pharma Ltd—

Categories (CPV)

Similar open tenders

About The NHS Commissioning Board (operating under the name of NHS England)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.